Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449416) titled 'Ceribell Delirium Monitor Outcomes Pilot Study' on Feb. 27.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Screening. Masking: None (Open Label).

Primary Sponsor: Ceribell Inc.

Condition: Delirium in the Intensive Care Unit

Intervention: Device: Ceribell Delirium Monitoring System

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 15, 2026

Target Sample Size: 100

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07449416

Published by HT Digital ...